Director, Consumer Marketing
Acadia Pharmaceuticals Inc. · Princeton, NJ +2 places
$198k–$248k/yrHybrid
Summit TherapeuticsPrinceton, NJ12+ years experience
$220k–$270k/yr listed by the employer
The employer took it down 3 days ago, after 18 days open. Here are similar open jobs.
Acadia Pharmaceuticals Inc. · Princeton, NJ +2 places
$198k–$248k/yrHybrid
Red Bull · Harrison, NJ
$108k–$162k/yrFull-time
New Jersey Future, Inc. · Trenton, NJ
$75k–$105k/yrFull-timeHybrid
Real Chemistry · Remote · US only
$135k–$155k/yr
Grant Thornton US · Chicago, IL +43 places
$104k–$135k/yrHybrid
CentralReach · Holmdel, NJ
$175k–$200k/yrHybrid
Summarised from the posting by AI and can be wrong. The full description is the source.
From Summit Therapeutics’ careers site
About Summit:
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC)
-
HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
-
HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
-
HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
Colorectal Cancer (CRC)
-
HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Overview of Role:
The Senior Director of Regional Marketing leader will play a critical role in supporting the successful commercialization of Summit Therapeutics' oncology portfolio by establishing and leading the Company's U.S. regional marketing strategy, capabilities, and organization. This role will translate overarching brand and commercial strategies into differentiated regional approaches that address market dynamics, customer needs, and opportunities to maximize business impact.
The Senior Director will build, recruit, develop, and lead a high-performing team of Regional Marketing Directors, establishing the vision, operating model, capabilities, and processes required to support effective regional customer engagement and commercial execution. The role will provide strategic direction and coaching to the regional marketing team while maintaining accountability for the quality, consistency, and impact of regional strategies and initiatives.
Role and Responsibilities:
Regional Marketing Strategy & Leadership
-
Team Leadership & Organizational Development
-
Customer & Thought Leader Engagement Strategy
-
Market & Customer Insights
-
Congress & Customer Engagement Strategy
-
Cross-Functional Leadership
-
Compliance & Governance
-
Experience, Education and Specialized Knowledge and Skills:
This is the pay for this position
Pay Transparency
$220,000—$270,000 USD
Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
Something wrong with this job? Report it · This flag looks wrong